USD 425.33 million
Viral Inactivation Market Size, Share, Growth Analysis, By Product(Chemical method, physical methods, and biological methods), By Application(Vaccines, biologics, blood products, and others), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35H2143 |
Region:
Global |
Published Date: February, 2024
Pages:
157
|Tables:
64
|Figures:
75
Viral Inactivation Market Insights
Viral Inactivation Market size was valued at USD 536.4 million in 2022 and is poised to grow from USD 602.37 million in 2023 to USD 1523.72 million by 2031, at a CAGR of 12.3% during the forecast period (2024-2031).
The global viral inactivation market is poised for substantial growth, driven by the expanding need for effective and safe viral clearance measures in the fields of pharmaceuticals, biotechnology, and healthcare.
With the rise in biopharmaceutical production and the increasing demand for safe medical treatments, viral inactivation has become a critical step to ensure the elimination of infectious viruses from biological products, vaccines, and therapeutic formulations.
Market analysis underscores the significance of regulatory compliance, as stringent guidelines and standards set by organizations such as the FDA and EMA propel companies to adopt robust viral inactivation techniques to mitigate the risk of viral contamination.
A pivotal factor in the market's growth trajectory is the increasing adoption of single-use technologies and disposable systems in biomanufacturing processes. These technologies not only streamline production but also minimize the risk of cross-contamination, rendering them compatible with the principles of viral risk reduction.
Additionally, the surge in outsourcing activities in the pharmaceutical and biotechnology sectors has contributed to the demand for outsourced viral inactivation services, propelling contract research organizations (CROs) to play a crucial role in the market.
As the global viral inactivation market witnesses technological advancements, regulatory compliance imperatives, and the ongoing pursuit of safer and more efficient methods, it presents a landscape characterized by opportunities for market players to differentiate through innovative offerings and strategic collaborations.
Amidst the challenges of viral threats and the imperatives of public health safety, the market is poised for sustained growth as industries continue to prioritize viral clearance and the delivery of high-quality, uncontaminated biopharmaceutical products and therapies.
US Viral Inactivation Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2024-2031
Global Market Size
Largest Segment
chemical method
Fastest Growth
chemical method
Growth Rate
12.3% CAGR
Global Viral Inactivation Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Viral Inactivation Market Segmental Analysis
The global viral inactivation market is segmented by product, application, end user and region. By product, the market is segmented into chemicals, physical methods, and biological methods. By application, the market is segmented into vaccines, biologics, blood products, and others. By end user, the market is segmented into pharmaceutical and biotechnology companies, hospitals and clinics, blood banks, and research laboratories. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Viral Inactivation Market Analysis By Product
Within the dynamic realm of the global viral inactivation market, two segments emerge as paramount forces, each shaping the industry's trajectory with distinct vigor. With a comprehensive range of chemical agents tailored to diverse viral strains, this segment resonates as a cornerstone of viral safety, instilling confidence in industries reliant on flawless medical treatments and biopharmaceuticals.
Yet, it's the biological methods segment that unfurls as the fastest-growing star, racing ahead at a remarkable 68% year-on-year expansion rate. In an era where biotechnology is scaling new heights, this segment taps into the ingenuity of nature itself, leveraging living organisms and their processes to neutralize viral contaminants. As industries propel towards safer and more sustainable viral inactivation practices, the biological methods segment unfurls as the beacon of transformative possibilities, propelling the global viral inactivation market towards a future where nature and innovation dance in unison.
Viral Inactivation Market Analysis By Application
Amidst the captivating landscape of the global viral inactivation market, two distinctive application segments emerge as driving forces, each leaving an indelible mark on the industry's trajectory. With the escalating demand for vaccines to combat an array of infectious diseases, the significance of viral inactivation in this domain becomes paramount, a shield that protects communities and individuals worldwide.
However, it's the biologics segment that emerges as the fastest growing luminary, surging forward with an electrifying 62% year-on-year expansion rate. In an era marked by a biopharmaceutical revolution, the significance of therapeutic biologics continues to soar. As breakthrough biologics unlock new dimensions in patient care, the biologics application segment dazzles as the harbinger of transformative medical possibilities, accelerating the global viral inactivation market into an era of precision treatments and visionary healthcare.
Global Viral Inactivation Market By Product
To get detailed analysis on other segments, Request For Free Sample Report
Viral Inactivation Market Regional Insights
In the captivating tapestry of the global viral inactivation market, two regions emerge as the guiding stars, shaping the industry's trajectory with their distinct vibrancy. North America, standing as the dominating colossus, casts its influence with visionary strides and technological prowess. Commanding an impressive 40% of the market share, this region boasts an advanced biopharmaceutical landscape, where stringent regulatory standards harmonize with cutting-edge research and development.
Simultaneously, the Asia-Pacific region, akin to a rising phoenix, blazes a trail of rapid growth with a captivating 68% year-on-year expansion rate. Fueled by a surge in pharmaceutical and biotechnology investments, this region is a cradle of innovation, fueled by an insatiable appetite for groundbreaking therapies and treatments. As North America spearheads excellence and the Asia-Pacific surges forth with unparalleled dynamism, the global viral inactivation market embarks on a journey where established expertise and emerging potential converge in a symphony of transformative healthcare possibilities.
Global Viral Inactivation Market By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Viral Inactivation Market Dynamics
Viral Inactivation Market Drivers
Biopharmaceutical Advancements
- The surge in biopharmaceutical research and development, particularly in areas such as monoclonal antibodies, gene therapies, and personalized medicine, drives the demand for effective viral inactivation methods. As the production of complex biologics and advanced therapies grows, ensuring viral safety becomes paramount to maintain the integrity and safety of these treatments. This driver is propelled by the need for stringent regulatory compliance and the quest for high-quality, uncontaminated biopharmaceutical products.
Viral Inactivation Market Restraints
Complex Regulatory Landscape
- The stringent and evolving regulatory landscape in the pharmaceutical and biotechnology sectors presents a challenge for the viral inactivation market. Navigating the intricate requirements set by regulatory authorities such as the FDA and EMA can be arduous and time-consuming. Companies must invest in comprehensive validation studies and documentation to demonstrate the effectiveness of their viral inactivation processes, which can lead to increased time and costs.
Request Free Customization of this report to help us to meet your business objectives.
Viral Inactivation Market Competitive Landscape
The competitive landscape of the global viral inactivation market portrays a captivating arena defined by innovation, regulatory compliance, and a pursuit of excellence in viral safety. Esteemed players, ranging from established industry giants to agile biotechnology startups, engage in a dynamic dance to offer cutting-edge viral inactivation solutions. Companies are propelled by the imperative to address the complex needs of biopharmaceutical production, vaccines, and therapeutic advancements. The landscape thrives on diverse technological approaches, from chemical agents to biological methods, each vying to establish superiority in efficacy, speed, and cost-effectiveness. Partnerships, collaborations, and strategic acquisitions are strategic maneuvers, enabling providers to harness synergies, expand their global footprint, and enhance their offerings. As industries continue to emphasize viral safety and the purity of medical products, the competitive terrain evolves into a dynamic arena where innovation, regulatory expertise, and technological finesse define the race towards safeguarding public health and advancing pharmaceutical breakthroughs.
Viral Inactivation Market Top Player’s Company Profiles
- Merck KGaA - Germany
- Pfizer Inc. - United States
- Danaher Corporation - United States
- Charles River Laboratories International, Inc. - United States
- Lonza Group Ltd. - Switzerland
- SGS SA - Switzerland
- Sartorius AG - Germany
- Avantor, Inc. - United States
- Texcell, Inc. - France
- Viral Clear LLC - United States
- BioReliance (Sigma-Aldrich Corporation) - United States
- Clean Cells - France
- Wuxi Biologics - China
- Catalent, Inc. - United States
- Eurofins Scientific SE - Luxembourg
- Vironova AB - Sweden
- GE Healthcare - United States
- Avance Biosciences - United States
- Nelson Laboratories, LLC (STERIS) - United States
- BioMérieux SA - France
Viral Inactivation Market Recent Developments
- In April 2023, Lonza Group announced the launch of its new Inactivated Virus Solution.
- In May 2023, Sartorius AG announced the launch of its new Viral Inactivation Service.
Viral Inactivation Key Market Trends
Rise in Biopharmaceutical Manufacturing
- The growing prominence of biopharmaceuticals, including monoclonal antibodies, gene therapies, and cell-based therapies, is driving the demand for advanced viral inactivation techniques. As these complex biologics gain traction for their targeted and personalized therapeutic applications, the need for stringent viral safety measures becomes paramount. The trend reflects the industry's shift towards novel treatment modalities and the integration of advanced technologies, contributing to the expansion of the viral inactivation market.
Shift towards Continuous Manufacturing
- The industry is experiencing a shift from traditional batch manufacturing to continuous manufacturing processes. Continuous manufacturing offers benefits such as increased efficiency, reduced costs, and enhanced quality control. In the context of viral inactivation, this trend impacts the development of technologies that can seamlessly integrate into continuous manufacturing setups, ensuring real-time and consistent viral clearance. This transition aligns with the industry's pursuit of streamlined production and faster time-to-market, reshaping the landscape of viral inactivation methodologies.
Viral Inactivation Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyzes the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to our analysis, the viral inactivation industry reveals a landscape defined by a harmonious blend of regulatory compliance, technological innovation, and evolving healthcare needs. As pharmaceutical and biotechnology sectors surge ahead, the imperative of viral safety stands as a pivotal driver, propelling the adoption of advanced viral inactivation methods. The market's trajectory is marked by a fervent pursuit of regulatory adherence, with companies investing in rigorous validation studies to ensure their processes meet stringent guidelines set by regulatory bodies such as the FDA and EMA. Moreover, technological innovation takes center stage, as companies strive to develop cutting-edge viral inactivation technologies that guarantee the efficacy and safety of biopharmaceutical products, gene therapies, and vaccines. This evolution is further propelled by the rising demand for targeted treatments and personalized medicine. In a landscape defined by patient-centric healthcare, the viral inactivation market reflects a harmonious synergy of healthcare advancements, regulatory diligence, and scientific innovation, poised to contribute significantly to the future of medical therapies and treatments.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 536.4 million |
| Market size value in 2031 | USD 1523.72 million |
| Growth Rate | 12.3% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Million |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Viral Inactivation Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Viral Inactivation Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Viral Inactivation Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Viral Inactivation Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Viral Inactivation Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Viral Inactivation Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
